Sutro Biopharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
21.38
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
6
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.65
|
0.00
|
0.65
|
100.00%
|
|
2022-09-30
|
-0.74
|
-0.37
|
0.37
|
50.00%
|
|
2022-06-30
|
-0.46
|
-0.55
|
-0.09
|
-19.57%
|
|
2022-03-31
|
-0.76
|
-0.84
|
-0.08
|
-10.53%
|
|
2021-12-31
|
-0.69
|
-0.83
|
-0.14
|
-20.29%
|
|
2021-09-30
|
-0.65
|
-0.67
|
-0.02
|
-3.08%
|
|
2021-06-30
|
-0.41
|
-0.13
|
0.28
|
68.29%
|
|
2021-03-31
|
-0.60
|
-0.66
|
-0.06
|
-10.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.76
|
|
2021-12-31
|
-2.29
|
|
2020-12-31
|
-0.93
|
|
2019-12-31
|
-2.06
|
|
2018-12-31
|
-22.89
|